PULMATRIX, INC. Derivative Liability, Current
PULMATRIX, INC. (PULM) had Derivative Liability, Current of $1.00 thousand as of 2018-03-31, per its 10-Q filed 2018-05-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2018-11-14
- 2018-03-31: Derivative Liability, Current $1.00K.
- 2017-12-31: Derivative Liability, Current $1.00K.
| Period end | Derivative Liability, Current |
|---|---|
| 2018-03-31 | $1.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $1.00K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |